Header Logo

Connection

WILLIAM K PLUNKETT JR to Safety

Back to Details
This is a "connection" page, showing publications WILLIAM K PLUNKETT JR has written about Safety.
WILLIAM K PLUNKETT JR
Connection Strength
0.013
Safety
  1. Phase I and pharmacodynamic study of Triapine, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia. Leuk Res. 2003 Dec; 27(12):1077-83.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.